Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 147.19M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 2.03%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 10.31%
Short ratioDays to cover, as published by FINRA: 8.67
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 51.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 38.90%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for ACRS

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 79.52%
Operating marginTTM to Jun 26: -1050.16%
Net margin: —
EBITDA marginTTM to Jun 26: -1045.04%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -59.10%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -41.07%

Growth

Revenue growth (annual YoY): -58.19%
Revenue growth (latest qtr YoY): -8.33%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: -0.58
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $19.16M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $1.85M
Debt / equityas of Jun 26: 1.48%
Current ratioas of Jun 26: 3.46
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 25: 3.73
Operating cash flowTTM to Jun 26: -$62.05M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$62.17M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.06

ACRS stock Statistics — Aclaris Therapeutics, Inc. filings, insiders & smart money · Instaport